MRI developer Advanced NMR plans to merge with its Advanced MammographySystems subsidiary, of which it presently owns 61%. On completionof the deal, AMS will operate as a wholly owned subsidiary ofAdvanced NMR, of Wilmington, MA. In other Advanced NMR
MRI developer Advanced NMR plans to merge with its Advanced MammographySystems subsidiary, of which it presently owns 61%. On completionof the deal, AMS will operate as a wholly owned subsidiary ofAdvanced NMR, of Wilmington, MA.
In other Advanced NMR news, the company said that it has extendedits contract with GE Medical Systems in which ANMR is the exclusivesystems integrator for GE 3- and 4-tesla research MRI scanners.Each sale of a very-high-field scanner will result in a minimumpayment of $1.5 million to ANMR. The deal extends through 1999.
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.